Abstract
Mucormycosis is one of the most severe and quickly spreading types of fungal illness which typically starts in the nose and paranasal sinuses after inhaling fungal spores. The subphylum Mucormycotina, which includes the genera Absidia, Mucor, Rhizomucor, and Rhizopus is responsible for its majority of cases of mucormycosis. There are roughly 1.7 incidences of mucormycosis per 1,000,000 people annually. Most common risk factors identified in patients with mucormycosis are immunocompromised patients, acidosis, increased serum free iron levels. Diabetic patients (immunosuppressed) with diabetic keto acidosis (DKA) are more prone for mucormycosis. Rhinocerebral mucormycosis which is the most frequently documented form of the condition, is characterized by a gradual fungal invasion of the hard palate, paranasal sinuses, orbit, and brain. Early disease detection and strong medical and surgical interventions are necessary for the successful management of this fulminant infection to reduce the significant morbidity and mortality linked to the disease course. Therefore, early detection of potentially fatal mucormycosis and timely treatment are crucial for lowering the fatality rate. Recently, there have been more reports of people with mucormycosis linked to COVID-19, particularly from India. We discuss a 52-year-old male patient with diabetes who developed rhinocerebral mucormycosis after a tooth extraction.
Published on: February 20, 2024
doi: 10.17756/micr.2024-101
Citation: Namilakonda S, Nagasri MT, Reddy PS, Pasuleti A. 2024. A Rare Case Report of Mucormycosis Presenting with Left External Ophthalmoplegia. J Med Imaging Case Rep 8(1): 1-4.
Downloads